Neo Ivy Capital Management Amgen Inc Transaction History

Neo Ivy Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$214.27 - $253.37 $368,972 - $436,303	-1,722 Reduced 51.53%	1,620 $359,000
Q4 2022 Mar 24, 2023	BUY	$229.03 - $291.01 $765,418 - $972,555	3,342 New	3,342 $877,000
Q1 2021 Oct 07, 2021	SELL	$221.91 - $258.6 $56,808 - $66,201	-256 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $55,393 - $65,963	256 New	256 $59,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $148B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.